During normal conditions, OXPHOS produces ATP in mitochondria and normally hinders NOX4‐derived ROS, whereas during metabolic reprogramming of cancer cells and switching to glycolysis, ATP is generated in the cytosol and mitochondrial ATP homeostasis is disrupted, which leads to NOX4 activation. Here, NOX4 is linked to cancer.